Skip to main content
. 2019 Oct 25;10:2514. doi: 10.3389/fimmu.2019.02514

Table 4.

Characterization for tumor cells presence and for TRAIL-R2 expression of three ovarian malignant ascites.

Malignant ascites ID % tumor cells (EpCAM+CD45) % TRAIL-R2+ tumor cells
PT #1 7.8 19.2
PT #7 0.5 35.0
PT #8 15.0 70.3